Table 2. Comparison analysis of reviewers with or without personal financial ties to industry.
Percentage of reviewers of the total with or without ties responding that the statements below are likely or very likely to be true | N = Total reviewers without financial ties | N = Total reviewers with financial ties | X2 | p | Fisher p |
Only FDA indications mentioned in physician speakers lectures | 80 (49%) | 62 (66%) | 4.3 | 0.04 | 0.04 |
Company provides the physician speaker with the prescribing patterns of the audience | 65 (71%) | 49 (51%) | 4.6 | 0.03 | 0.03 |
Presentation expected to be consistent with the company's marketing message | 82 (99%) | 66 (88%) | 7.6 | 0.006 | 0.01 |
Consultant provides the company with the names of community physician opinion leaders | 82 (98%) | 61 (89%) | 4.8 | 0.028 | 0.04 |
Consultant acts as a liaison with community physicians with the goal of promoting the company's products | 82 (84%) | 62 (68%) | 5.4 | 0.03 | 0.03 |
Consultant reluctant to jeopardize the continuation of a working relationship with the company. | 87 (87%) | 66 (74%) | 4.3 | 0.04 | 0.06 |
Guarantees of future collaborative projects with the sponsor are likely to bias an author. | 89 (93%) | 66 (79%) | 7.1 | 0.008 | 0.01 |